Erika F. Augustine

2.4k total citations
69 papers, 879 citations indexed

About

Erika F. Augustine is a scholar working on Physiology, Genetics and Clinical Psychology. According to data from OpenAlex, Erika F. Augustine has authored 69 papers receiving a total of 879 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Physiology, 15 papers in Genetics and 14 papers in Clinical Psychology. Recurrent topics in Erika F. Augustine's work include Lysosomal Storage Disorders Research (32 papers), Glycogen Storage Diseases and Myoclonus (14 papers) and Genomics and Rare Diseases (12 papers). Erika F. Augustine is often cited by papers focused on Lysosomal Storage Disorders Research (32 papers), Glycogen Storage Diseases and Myoclonus (14 papers) and Genomics and Rare Diseases (12 papers). Erika F. Augustine collaborates with scholars based in United States, Germany and France. Erika F. Augustine's co-authors include Jonathan W. Mink, Heather Adams, Frederick J. Marshall, Amy Vierhile, Jennifer M. Kwon, Katherine Rose, Christopher A. Beck, Tanya K. Murphy, Leon Dure and Elisabeth A. de Blieck and has published in prestigious journals such as JAMA, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Erika F. Augustine

61 papers receiving 866 citations

Peers

Countries citing papers authored by Erika F. Augustine

Since Specialization

Citations

This map shows the geographic impact of Erika F. Augustine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erika F. Augustine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erika F. Augustine more than expected).

Fields of papers citing papers by Erika F. Augustine

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erika F. Augustine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erika F. Augustine. The network helps show where Erika F. Augustine may publish in the future.

Co-authorship network of co-authors of Erika F. Augustine

This figure shows the co-authorship network connecting the top 25 collaborators of Erika F. Augustine. A scholar is included among the top collaborators of Erika F. Augustine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erika F. Augustine. Erika F. Augustine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A timeline of symptom onset and disease progression in CLN3 disease 2026 ·Orphanet Journal of Rare Diseases ·(unknown), Anthony L. Cook, Erika F. Augustine, Aidan Bindoff, (unknown), (unknown), Jonathan W. Mink, John R. Østergaard, Angela Schulz, (unknown), Amy Vierhile, Heather Adams	0
2	From roadmap to a sustainable end-to-end individualized therapy pathway 2025 ·PubMed ·Anneliene Hechtelt Jonker, (unknown), David Dimmock, Alison Bateman-House, Holm Graeßner, Gareth Baynam, Erika F. Augustine, Adam Jaffé, Anna M.G. Pasmooij, (unknown), Richard Horgan, James Davies, (unknown), Larissa Lapteva, Matthis Synofzik, Timothy W. Yu, Daniel O’Connor, Annemieke Aartsma‐Rus	1
3	Assessing the integrity of auditory sensory memory processing in CLN3 disease (Juvenile Neuronal Ceroid Lipofuscinosis (Batten disease)): an auditory evoked potential study of the duration-evoked mismatch negativity (MMN) 2024 ·Journal of Neurodevelopmental Disorders ·Tufikameni Brima, Edward G. Freedman, (unknown), Erika F. Augustine, Heather Adams, Kuan Hong Wang, Jonathan W. Mink, (unknown), (unknown), John J. Foxe	3
4	A framework for N-of-1 trials of individualized gene-targeted therapies for genetic diseases 2024 ·Nature Communications ·(unknown), Joseph G. Gleeson, Laurence Mignon, (unknown), Winston X. Yan, (unknown), Scott Demarest, Elizabeth Berry‐Kravis, Richard S. Finkel, (unknown), Samuel G. Finlayson, Erika F. Augustine, Gholson J. Lyon, Rebecca Schüle, Timothy W. Yu	7
5	Data sharing to advance gene‐targeted therapies in rare diseases 2023 ·American Journal of Medical Genetics Part C Seminars in Medical Genetics ·(unknown), Erika F. Augustine, Amy Brower, Thomas Defay, Richard S. Finkel, Amy L. McGuire, Mark W. Skinner, Timothy W. Yu	7
6	Recognizing and Responding to the Needs of Future Child and Adult Neurology Care Through the Evolution of Residency Training 2023 ·Annals of Neurology ·Justin C. McArthur, Erika F. Augustine, S. Thomas Carmichael, Donna M. Ferriero, Frances E. Jensen, Shafali Jeste, Lori C. Jordan, R. Llinás, Bradley L. Schlaggar, Lisa R. Sun, Scott L. Pomeroy	2
7	Gene‐targeted therapies: Towards equitable development, diagnosis, and access 2023 ·American Journal of Medical Genetics Part C Seminars in Medical Genetics ·Amy Gaviglio, Mark W. Skinner, (unknown), Richard S. Finkel, Erika F. Augustine, Aaron J. Goldenberg	10
8	Moving away from one disease at a time: Screening, trial design, and regulatory implications of novel platform technologies 2023 ·American Journal of Medical Genetics Part C Seminars in Medical Genetics ·(unknown), Philip J. Brooks, Dwight D. Koeberl, Amy Brower, Aaron J. Goldenberg, Robert C. Green, Jill A. Morris, Joseph J. Orsini, Timothy W. Yu, Erika F. Augustine	5
9	Utilizing the Un-Meeting model to advance innovative translational and team science 2023 ·Journal of Clinical and Translational Science ·Erika F. Augustine, (unknown), Scott McIntosh, (unknown), (unknown), Reza Yousefi‐Nooraie, Martin S. Zand, Deborah J. Ossip	0
10	Experimental Neurotherapeutics: Surfing the Tidal Wave of New Opportunities 2022 ·Annals of Neurology ·Lauren Reoma, Ania Busza, M. Maral Mouradian, Petra Kaufmann, Erika F. Augustine, (unknown), Thomas P. Sutula, Andrew J. Cole, (unknown), William J. Meurer, Avindra Nath, Robert C. Griggs	1
11	Management of CLN1 Disease: International Clinical Consensus 2021 ·Pediatric Neurology ·Erika F. Augustine, Heather Adams, Emily de los Reyes, (unknown), (unknown), Norberto Guelbert, Minna Laine, (unknown), Jonathan W. Mink, Miriam Nickel, (unknown), Angela Schulz, Alessandro Simonati, Meral Topçu, Joni A. Turunen, Ruth Williams, Elaine Wirrell, (unknown)	17
12	Risk Behaviors in Youth With and Without Tourette Syndrome 2021 ·Pediatric Neurology ·(unknown), Erika F. Augustine, Heather Adams, Amy Vierhile, (unknown), Michael McDermott, Thomas G. O’Connor, Roger Kurlan, Edwin van Wijngaarden, Jonathan W. Mink	4
13	A Virtual Cohort Study of Individuals at Genetic Risk for Parkinson’s Disease: Study Protocol and Design 2020 ·Journal of Parkinson s Disease ·Ruth B. Schneider, Taylor Myers, (unknown), Marie K. Luff, (unknown), Saloni Sharma, Renée Wilson, Stella Jensen-Roberts, Peggy Auinger, Michael McDermott, Roy N. Alcalay, Kevin Biglan, (unknown), Caroline M. Tanner, (unknown), Erika F. Augustine, Paul J. Cannon, Robert G. Holloway, E. Ray Dorsey	5
14	Short-Term Administration of Mycophenolate Is Well-Tolerated in CLN3 Disease (Juvenile Neuronal Ceroid Lipofuscinosis) 2018 ·JIMD Reports ·Erika F. Augustine, Christopher A. Beck, Heather Adams, (unknown), Amy Vierhile, Derek Timm, Jill M. Weimer, Jonathan W. Mink, Frederick J. Marshall	23
15	Design of a Multisite Study Assessing the Impact of Tic Disorders on Individuals, Families, and Communities 2016 ·Pediatric Neurology ·Erika F. Augustine, Heather Adams, Rebecca H. Bitsko, Edwin van Wijngaarden, Angelika H. Claussen, (unknown), Camille E. Hanks, Adam B. Lewin, Tom O’Connor, Amy Vierhile, Melissa L. Danielson, Roger Kurlan, Tanya K. Murphy, Jonathan W. Mink	10
16	Sex Differences in Clinical Features of Early, Treated Parkinson’s Disease 2015 ·PLoS ONE ·Erika F. Augustine, Adriana Pérez, Rohit Dhall, Chizoba C. Umeh, Aleksandar Videnović, Franca Cambi, Anne‐Marie Wills, Jordan J. Elm, Richard M. Zweig, Lisa M. Shulman, Martha Nance, Jacquelyn Bainbridge, Oksana Suchowersky	56
17	Utility of the Diagnostic Interview Schedule for Children for Assessing Tourette Syndrome in Children 2014 ·Journal of Child and Adolescent Psychopharmacology ·Adam B. Lewin, Jonathan W. Mink, Rebecca H. Bitsko, Joseph R. Holbrook, E. Carla Parker-Athill, Camille E. Hanks, Eric A. Storch, Erika F. Augustine, Heather Adams, Amy Vierhile, (unknown), Tanya K. Murphy	14
18	Methodology of clinical research in rare diseases: Development of a research program in juvenile neuronal ceroid lipofuscinosis (JNCL) via creation of a patient registry and collaboration with patient advocates 2013 ·Contemporary Clinical Trials ·Elisabeth A. de Blieck, Erika F. Augustine, Frederick J. Marshall, Heather Adams, (unknown), Leon Dure, Jennifer M. Kwon, (unknown), Katherine Rose, Paul G. Rothberg, Amy Vierhile, Jonathan W. Mink	21
19	Experience, knowledge, and opinions about childhood genetic testing in Batten disease 2013 ·Molecular Genetics and Metabolism ·Heather Adams, Katherine Rose, Erika F. Augustine, Jennifer M. Kwon, Elisabeth A. deBlieck, Frederick J. Marshall, Amy Vierhile, Jonathan W. Mink, Martha Nance	11
20	Females experience a more severe disease course in batten disease 2011 ·Journal of Inherited Metabolic Disease ·(unknown), Heather Adams, Erika F. Augustine, Frederick J. Marshall, Jennifer M. Kwon, (unknown), Amy Vierhile, (unknown), Leon Dure, Katherine Rose, Denia Ramirez‐Montealegre, Elisabeth A. de Blieck, Jonathan W. Mink	52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact